Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-09-11 Purchase |
2024-09-12 06:32 am |
KIORA PHARMACEUTICALS INC | KPRX | Stengone Carmine N. Director |
1,250 | $3.68 | $4,600 | 1,250 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-04-01 Option Award |
2025-04-02 8:11 pm |
2026-04-01 2035-04-01 |
KIORA PHARMACEUTICALS INC | KPRX | Stengone Carmine N. Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2025-01-31 Option Award |
2025-01-31 4:35 pm |
N/A 2035-01-30 |
Contineum Therapeutics Inc. | CTNM | Stengone Carmine N. CEO and President |
300,000 | $0 | 300,000 (Direct) |
View |
| 2024-07-01 Option Award |
2024-07-03 3:16 pm |
2025-07-01 2034-07-01 |
KIORA PHARMACEUTICALS INC | KPRX | Stengone Carmine N. Director |
1,778 | $0 | 1,778 (Direct) |
View |
| 2024-05-24 Option Award |
2024-05-29 5:59 pm |
N/A 2034-05-23 |
Contineum Therapeutics Inc. | CTNM | Stengone Carmine N. CEO and President |
285,000 | $0 | 285,000 (Direct) |
View |
Ownership |
2024-04-04 5:49 pm |
N/A N/A |
Contineum Therapeutics Inc. | CTNM | Stengone Carmine N. CEO and President |
0 | $0 | 981,519 (Direct) |
View |
| 2023-09-29 Option Award |
2023-10-03 4:45 pm |
N/A 2033-09-29 |
KIORA PHARMACEUTICALS INC | KPRX | Stengone Carmine N. Director |
8,000 | $0 | 8,000 (Direct) |
View |